Association between G-308 A polymorphism of the tumor necrosis factor-α gene and 24-hour ambulatory blood pressure values in type 1 diabetic adolescents

Clinical Genetics

Volumn 62, Issue 6, 2002, Pages 474-477

  Krikovszky, D ^a   Vasarhelyi B ^b   Toth Heyn P ^a   Korner A ^a   Tulassay, T ^a   Madacsy L ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Research Laboratory of Paediatrics and Nephrology   (Hungary)

Author keywords

Ambulatory blood pressure monitoring; Genetic polymorphism; Tumor necrosis factor ; Type 1 diabetes mellitus

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ALLELE; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DIASTOLIC BLOOD PRESSURE; ETHNIC DIFFERENCE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REFERENCE VALUE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CHILD; GENE FREQUENCY; GENETICS; HUNGARY; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CHILD; DIABETES MELLITUS, TYPE 1; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HUNGARY; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036957894     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2002.620609.x     Document Type: Article

References (21)

1. Abbas AK, Lichtman AH, Pober JS. Cellular and Molecular Immunology, 3rd edn., W. B. Saunders Company, 1997, pp 258-260.
2. Libby P. Vascular cells produce and respond to cytokines. In: Hansson GK, Libby P, eds. Immune function of the vessel wall. The Netherlands: Harwood Academic Publishers, 1996, pp 56-64.
3. Kahaleh MB, Fan PS. Effect of cytokines on the production of endothelin by endothelial cells. Clin Exp Rheumatol 1997: 15: 163-167.
4. Dörffel Y, Latsch C, Stuhlmüller B et al. Preactivated peripheral blood monocytes in patients with essential hypertension. Hypertension 1999: 34: 113-117.
5. Ito H, Ohshima A, Tsuzuki M et al. Association of serum tumour necrosis factor-alpha with serum low-density lipo-protein-cholesterol and blood pressure in apparently healthy Japanese women. Clin Exp Pharmacol Physiol 2001: 28: 188-192.
6. Zietz B, Schaffler A, Buttner R, Scholmerich J, Palitzsch KD. Elevated levels of leptin and insulin, but not of TNF alpha, are associated with hypertension in type 2 diabetic males. Exp Clin Endocrinol Diabetes 2000: 108: 259-264.
7. Louis E, Franchimont D, Piron A et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998: 113: 401-406.
8. Cox A, Gonzalez AM, Wilson AG et al. Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor alpha with human IDDM. Diabetologia 1994: 37: 500-503.
9. Soerger M, Kirschstein M, Busch C et al. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 1997: 130: 178-184.
10. Farmer CK, Goldsmith DJ, Quin JD et al. Progression of diabetic nephropathy - is diurnal blood pressure rhythm as important as absolute blood pressure level? Nephrol Dial Transplant 1998: 13: 635-639.
11. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988: 16: 1215.
12. Szalai C, Fust G, Duba J et al. Association of polymorphisms and allelic combinations in the tumour necrosis factor-alpha-complement MHC region with coronary artery disease. J Med Genet 2002: 39: 46-51.
13. Toellen M, Buykaen AE, Heitkamp G, Berg G, Scherbaum WA. Prevalence of chronic complications, metabolic control and nutritional intake in type 1 diabetes: comparison between different European regions. EURODIAB Complications Study group. Horm Metab Res 1999: 31: 680-685.
14. Spallone V, Maiello MR, Cicconetti E et al. Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes. J Hum Hypertens 2001: 15: 239-246.
15. Monteagudo PT, Nobrega JC, Cezarini PR et al. Altered blood pressure profile, autonomic neuropathy and nephropathy in insulin-dependent diabetic patients. Eur J Endocrinol 1996: 135: 683-688.
16. Verrotti A, Chiarelli F, Morgese G. Autonomic dysfunction in newly diagnosed insulin-dependent diabetes mellitus children. Pediatr Neurol 1996: 14: 49-52.
17. Pausova Z, Deslauriers B, Gaudet D et al. Role of tumor necrosis factor-α gene locus in obesity, and obesity-associated hypertension in French Caucasians. Hypertension 2000: 36: 14-19.
18. Tesfamariam B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 1992: 263: H321-H326.
19. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993: 88: 2510-2516.
20. Granger JP, Alexander BT, Llinas MT, Bennett WA, Barbara TA, Khalil RA. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension 2001: 38: 718S-727S.
21. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Salvetti A. Endothelial dysfunction in hypertension. J Nephrol 2000: 13: 205-210.